Placebos are at heart of clinical-trial changes

04/21/2013 |

Tighter restrictions on the use of placebos, more protections for vulnerable populations, and compensation and treatment for individuals harmed in clinical trials are among the recent draft changes made by the World Medical Association to the Helsinki Declaration on medical research. Among the changes are provisions saying that researchers can use placebos only when no other reasonable option is available and they can target vulnerable patient groups only when they are unable to employ non-vulnerable populations.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT